Provided by Tiger Trade Technology Pte. Ltd.

Armata Pharmaceuticals, Inc.

10.63
-1.2300-10.37%
Post-market: 10.630.00000.00%16:35 EST
Volume:100.34K
Turnover:1.14M
Market Cap:387.01M
PE:-8.25
High:12.23
Open:12.19
Low:10.05
Close:11.86
52wk High:16.34
52wk Low:0.8981
Shares:36.41M
Float Shares:10.87M
Volume Ratio:1.20
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2882
EPS(LYR):-0.8886
ROE:-3439.35%
ROA:-22.20%
PB:-4.05
PE(LYR):-11.96

Loading ...

Amex Halt Add Info Lst 5.810000

THOMSON REUTERS
·
Nov 10, 2025

BRIEF-Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles

Reuters
·
Nov 10, 2025

Armata Pharmaceuticals Inc - FDA Notified of Production Commencement; No Issues Reported

THOMSON REUTERS
·
Nov 10, 2025

Health Rounds: Viruses may hold key to tackling deadly bacterial infection

Reuters
·
Oct 31, 2025

Amex Halt Add Info Lst 7.930000

THOMSON REUTERS
·
Oct 23, 2025

Amex Halt Add Info Lst 13.370000

THOMSON REUTERS
·
Oct 23, 2025

Amex Halt Add Info Lst 13.750000

THOMSON REUTERS
·
Oct 23, 2025

Amex Halt Add Info Lst 9.740000

THOMSON REUTERS
·
Oct 23, 2025

Amex Halt Add Info Lst 7.320000

THOMSON REUTERS
·
Oct 23, 2025

Armata's Blood-Infection Drug Shows Positive Results in Mid-Stage Trial

Dow Jones
·
Oct 23, 2025

Amex Halt Add Info Lst 5.500000

THOMSON REUTERS
·
Oct 22, 2025

Armata data support advancing AP-SA02 to Phase 3, says H.C. Wainwright

TIPRANKS
·
Oct 22, 2025

Armata Pharmaceuticals up 19% after reporting results of diSArm study

TIPRANKS
·
Oct 22, 2025

Amex Halt Add Info Lst 4.150100

THOMSON REUTERS
·
Oct 22, 2025

Armata says diSArm study confirms efficacy of intravenous phage therapy for SAB

TIPRANKS
·
Oct 22, 2025

Armata Pharmaceuticals Reports Positive Phase 2a Results for AP-SA02 in Staphylococcus aureus Bacteremia

Reuters
·
Oct 22, 2025

Armata Pharmaceuticals trading halted, news pending

TIPRANKS
·
Oct 22, 2025

Amex Halt News Pending Lst 3.491300

THOMSON REUTERS
·
Oct 22, 2025

Armata Pharmaceuticals to Present Phase 2a Clinical Data on AP-SA02 Bacteriophage Therapy for Staphylococcus aureus Bacteremia at IDWeek 2025

Reuters
·
Oct 14, 2025